Table 1. Available data from pivotal... | American Society of Hematology

Table 1.

Available data from pivotal clinical trials of populations with 3L+ R/R LBCL regarding V2VT

Study	N	Infused, n (%)	Median V2VT	Additional information
ZUMA-1⁴	111	101 (91)	24 d	V2VT range, 16-73 d
JULIET³	165	111 (67)	54 d	90% of patients infused between 30-92 d
TRANSCEND-NHL-001⁵	344	269 (78)	37 d	V2VT range, 27-224 d

Study	N	Infused, n (%)	Median V2VT	Additional information
ZUMA-1⁴	111	101 (91)	24 d	V2VT range, 16-73 d
JULIET³	165	111 (67)	54 d	90% of patients infused between 30-92 d
TRANSCEND-NHL-001⁵	344	269 (78)	37 d	V2VT range, 27-224 d